title: Pioglitazone: reports of its death are greatly exaggerated - it is alive and ready to resume saving lives.
authors.affiliation: Department of Diabetes and Endocrinology, City Hospital, Birmingham, UK.
authors.forename: R E J
authors.initials: RE
authors.lastname: Ryder
mesh_terms: D000818:Animals; D002273:Carcinogens / Q000633:toxicity*; D003925:Diabetic Angiopathies / Q000517:prevention & control*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D064887:Observational Studies as Topic; D000077205:Pioglitazone; D016032:Randomized Controlled Trials as Topic; D051381:Rats; D012307:Risk Factors; D056737:Safety-Based Drug Withdrawals; D045162:Thiazolidinediones / Q000009:adverse effects*; D014556:Urine
chemical_list: D002273:Carcinogens; D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077205:Pioglitazone